Skip to content

Cheek Acupuncture for Analgesia in Non-Intubated VATS Lung Surgery: A Randomized Trial

Cheek Acupuncture for Analgesia in Non-Intubated VATS Lung Surgery: A Randomized Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002365
Enrollment
Unknown
Registered
2025-12-01
Start date
2026-03-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Buccal needle group:Cheek Acupuncture Group
control group:Sham Cheek Acupuncture

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Patients scheduled for elective video-assisted thoracoscopic surgery (VATS) for pulmonary wedge resection 2) Aged 18 to 65 years; 3) American Society of Anesthesiologists (ASA) physical status classification = Class II; 4) Body mass index (BMI) <25 kg/m²; 5) Voluntarily participate and provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients who refused the proposed surgical and anesthetic protocols; 2) Contraindications to general or regional anesthesia including: Respiratory disorders: laryngeal edema acute laryngitis laryngeal submucosal hematoma severe asthma chronic obstructive pulmonary disease (COPD) recent severe upper respiratory infection or pneumonia Cardiovascular diseases: unstable angina poorly controlled hypertension (resting BP >160/100 mmHg) acute myocardial infarction within 6 months Coagulopathy Inadequate fasting duration (40 cm) Physical examination findings: • Mallampati class =II • Thyromental distance =6 cm • Mentohyoid distance =12 cm • Inadequate jaw protrusion (<1 cm advancement) • Restricted neck flexion-extension

Design outcomes

Primary

MeasureTime frame
Remifentanil consumption during operation;

Secondary

MeasureTime frame
Total intraoperative and 48-hour postoperative sufentanil consumption;Visual Analog Scale (VAS) scores assessed at: ??2 hours postoperatively (T1)?? ??6 hours postoperatively (T2)?? ??24 hours postoperatively (T3)?? ??48 hours postoperatively (T4)?;otal intraoperative consumption of propofol and vasoactive agents;Opioid dosage within 48 hours after surgery, calculated as morphine equivalents;Postoperative recovery time, extubation time and hospitalization time;Number of PCIA device compressions, effective compressions, and rescue analgesia within 48 hours after surgery;Adverse events such as postoperative vomiting (PONV), drowsiness, respiratory depression (SpO2 < 90%), and skin itching within 48 hours;The quality of recovery was scored using the postoperative QoR-15 scoring scale.;The Postoperative Quality Recovery Scale (PQRS) was used to evaluate the quality of postoperative recovery and patient satisfaction after anesthesia.;

Countries

China

Contacts

Public ContactJinhe Deng

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

pandanyang87@gmail.com13751803925

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026